US drug approvals
7 approvals with a product on the US market
- Lubiprostone ANDA221049 · approved 14 Oct 2026
- Nintedanib Esylate ANDA218472 · approved 9 Jul 2026
- Calcitriol ANDA219796 · approved 27 Feb 2026
- Icosapent Ethyl ANDA217919 · approved 22 Dec 2023
- Amantadine Hydrochloride ANDA214580 · approved 20 Dec 2022
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.